Investing.com -- Hims & Hers Health raised its full-year 2026 revenue forecast on Monday after reporting a 38% jump in second-quarter revenue, helped by subscriber growth and a sharp expansion of its international business.

The company now expects 2026 revenue of $3.1 billion to $3.3 billion, up from its previous forecast, and adjusted EBITDA of $275 million to $325 million. It expects third-quarter revenue of $880 million to $900 million and adjusted EBITDA of $75 million to $95 million.

The telehealth company reported revenue of $753.2 million for the quarter ended June 30, compared with $544.8 million a year earlier. Subscribers rose 19% to nearly 2.9 million, while U.S. revenue grew 16% and international revenue increased more than 17-fold following the June completion of its Eucalyptus acquisition.

Hims & Hers posted a net loss of $86.3 million, compared with net income of $42.5 million a year earlier. Adjusted EBITDA fell to $60.3 million from $82.2 million, while gross margin declined to 64% from 76%.

The company also reported free cash flow of negative $68.2 million, compared with negative $69.4 million a year earlier.

Hims & Hers said its international business continued to strengthen after the Eucalyptus deal, while domestic growth accelerated during the quarter.